학술논문

Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
Document Type
Article
Source
In: Leukemia and Lymphoma. (Leukemia and Lymphoma, 3 July 2018, 59(7):1659-1665)
Subject
Language
English
ISSN
10292403
10428194